These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33179845)

  • 1. A joint industry-sponsored data monitoring committee model for observational, retrospective drug safety studies in the real-world setting.
    Major-Pedersen A; McCullen MK; Sabol ME; Adetunji O; Massaro J; Neugut AI; Sosa JA; Hollenberg AN
    Pharmacoepidemiol Drug Saf; 2021 Jan; 30(1):9-16. PubMed ID: 33179845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing trial integrity by protecting the independence of data monitoring committees in clinical trials.
    Fleming TR; Hennekens CH; Pfeffer MA; DeMets DL
    J Biopharm Stat; 2014; 24(5):968-75. PubMed ID: 24926941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues in data monitoring and interim analysis of trials.
    Grant AM; Altman DG; Babiker AB; Campbell MK; Clemens FJ; Darbyshire JH; Elbourne DR; McLeer SK; Parmar MK; Pocock SJ; Spiegelhalter DJ; Sydes MR; Walker AE; Wallace SA;
    Health Technol Assess; 2005 Mar; 9(7):1-238, iii-iv. PubMed ID: 15763038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data monitoring committees: Promoting best practices to address emerging challenges.
    Fleming TR; DeMets DL; Roe MT; Wittes J; Calis KA; Vora AN; Meisel A; Bain RP; Konstam MA; Pencina MJ; Gordon DJ; Mahaffey KW; Hennekens CH; Neaton JD; Pearson GD; Andersson TL; Pfeffer MA; Ellenberg SS
    Clin Trials; 2017 Apr; 14(2):115-123. PubMed ID: 28359194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liability issues for data monitoring committee members.
    DeMets DL; Fleming TR; Rockhold F; Massie B; Merchant T; Meisel A; Mishkin B; Wittes J; Stump D; Califf R
    Clin Trials; 2004; 1(6):525-31. PubMed ID: 16279293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the independence of data monitoring committee in adaptive design clinical trials.
    Chow SC; Corey R; Lin M
    J Biopharm Stat; 2012; 22(4):853-67. PubMed ID: 22651119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "You have to keep your nerve on a DMC." Challenges for Data Monitoring Committees in neonatal intensive care trials: Qualitative accounts from the BRACELET Study.
    Snowdon C; Brocklehurst P; Tasker RC; Ward Platt M; Elbourne D
    PLoS One; 2018; 13(7):e0201037. PubMed ID: 30048484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing landscape of data monitoring committees-Perspectives from regulators, members, and sponsors.
    Bhattacharyya A; Gallo P; Crisp A; LaVange L; Molenberghs G; Pétavy F; Seltzer J
    Biom J; 2019 Sep; 61(5):1232-1241. PubMed ID: 30589102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Issues in regulatory guidelines for data monitoring committees.
    DeMets D; Califf R; Dixon D; Ellenberg S; Fleming T; Held P; Julian D; Kaplan R; Levine R; Neaton J; Packer M; Pocock S; Rockhold F; Seto B; Siegel J; Snapinn S; Stump D; Temple R; Whitley R
    Clin Trials; 2004; 1(2):162-9. PubMed ID: 16281888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsibilities of Data Monitoring Committees: Consensus Recommendations.
    Bierer BE; Li R; Seltzer J; Sleeper LA; Frank E; Knirsch C; Aldinger CE; Levine RJ; Massaro J; Shah A; Barnes M; Snapinn S; Wittes J
    Ther Innov Regul Sci; 2016 Sep; 50(5):648-659. PubMed ID: 30231760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical preparedness of data monitoring committees (DMCs) to oversee international clinical trials: a qualitative descriptive study.
    Hinga A; Ibrahim A; Vintimilla D; Jones M; Eckstein L; Rid A; Shah SK; Kamuya D
    BMJ Glob Health; 2024 Aug; 9(8):. PubMed ID: 39182924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases.
    Filippatos GS; de Graeff P; Bax JJ; Borg JJ; Cleland JG; Dargie HJ; Flather M; Ford I; Friede T; Greenberg B; Henon-Goburdhun C; Holcomb R; Horst B; Lekakis J; Mueller-Velten G; Papavassiliou AG; Prasad K; Rosano GM; Severin T; Sherman W; Stough WG; Swedberg K; Tavazzi L; Tousoulis D; Vardas P; Ruschitzka F; Anker SD
    Eur J Heart Fail; 2017 Apr; 19(4):449-456. PubMed ID: 28271595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stakeholders' Perspectives on Current Issues in Data Monitoring Committees.
    Cartwright MJ; Friede T; Lawrence D; May E; Mütze T; Roes K
    Biom J; 2024 Oct; 66(7):e202300384. PubMed ID: 39308116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the role and function of trial steering committees: results of an expert panel meeting.
    Harman NL; Conroy EJ; Lewis SC; Murray G; Norrie J; Sydes MR; Lane JA; Altman DG; Baigent C; Bliss JM; Campbell MK; Elbourne D; Evans S; Sandercock P; Gamble C
    Trials; 2015 Dec; 16():597. PubMed ID: 26715378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the functions and operations of data monitoring committees: Survey and focus group findings.
    Calis KA; Archdeacon P; Bain RP; Forrest A; Perlmutter J; DeMets DL
    Clin Trials; 2017 Feb; 14(1):59-66. PubMed ID: 27885056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoepidemiology 101: data monitoring committees in the post-marketing approval setting.
    Lilienfeld DE
    Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):381-5. PubMed ID: 15170767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Estimate of the Benefit-Cost Impact of the FDA Guidance on Data Monitoring Committees.
    Seltzer J
    Ther Innov Regul Sci; 2015 Sep; 49(5):698-705. PubMed ID: 30227033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19.
    Sandercock PAG; Darbyshire J; DeMets D; Fowler R; Lalloo DG; Munavvar M; Staplin N; Warris A; Wittes J; Emberson JR
    Trials; 2022 Oct; 23(1):881. PubMed ID: 36258219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data monitoring in randomized controlled trials: surveys of recent practice and policies.
    Clemens F; Elbourne D; Darbyshire J; Pocock S;
    Clin Trials; 2005; 2(1):22-33. PubMed ID: 16279576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.